Weight Gain After Switch from Efavirenz-Based to Integrase Inhibitor-Based Regimens

  • Norwood J
  • Turner M
  • Bofill C
  • et al.
N/ACitations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Poster Abstracts • OFID 2017:4 (Suppl 1) • S433 adjustment for other covariates. P value <0.05 was considered statistically significant. R version 3.3.2 was used for the statistical analysis. Results. A total of 70 women and 90 men were included in the study. Median age was 41 years (19) for women and 34 years (19) for men (P < 0.001). Virologic suppres-sion was documented in 76% of women and 64% of men (p 0.166). Immune recovery was documented in 60% of women and 68% of men (p 0.323). Multivariate analysis of virologic success is shown in Figure 1 and immunologic recovery is shown in Figure 2.

Cite

CITATION STYLE

APA

Norwood, J., Turner, M., Bofill, C., Jenkins, C., Bebawy, S., Rebeiro, P., … Koethe, J. (2017). Weight Gain After Switch from Efavirenz-Based to Integrase Inhibitor-Based Regimens. Open Forum Infectious Diseases, 4(suppl_1), S433–S433. https://doi.org/10.1093/ofid/ofx163.1094

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free